Nuclear Chemistry
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dr. A.A. El-Mohty Dr. Shoukar T.M. Atwa
Benha University Faculty of Science Chemistry Department RADIOCHEMICAL STUDIES ON THE SEPARATION OF IODINE- 131 AND RADIOIODINATION OF SOME ORGANIC COMPOUNDS A Thesis Submitted by MAHMOUD ABBAS ISMAIL MOHAMED Isotopes and Radioactive Generators Dep., Hot Labs. Center Atomic Energy Authority To Faculty of Science – Benha University Presented as partial fulfillment of The Degree of M.Sc In chemistry Supervised by Prof .Dr .H .A. Dessouki Prof . Dr .S .A .El -Bayoumy Prof. of Inorganic and Prof. of Radiochemistry Analytical Chemistry Isot. and Radio Generators.Dept, Faculty of Science Benha Univ. Atomic Energy Authority Dr. Shoukar T.M. Atwa Dr. A.A. El-Mohty Lect. of Physical Chemistry Pro Ass it. Prof.of Radiochemistry Faculty of Science Benha Univ. Isot. and Radio Generators.Dept, Atomic Energy Authority 2010 آ ام اء درات آ إ اد- ١٣١و اآت ا د ا ر ــــد س ا ا واات ا – آ ا ارة ه ا ار ا آــ اــــ ــم – ــ ل در ا اء اـــــــــاف أ.د/ ا ا أ.د/ د اذ اء ا و ا أذ اــء اـــ آ ام - ـــ ا واات ا هــــ اـــ ارــــــــ د/ ر أ.م.د / أ ا رس اء ا أذ اــء اـــ آ ام - ـــ ا واات ا هــــ اـــ ارــــــــ ٢٠١٠ List of abbreviations Abbr. Referent CAT Chloramine-T H2O2 Hydrogen peroxide HPLC High performance liquid chromatography TLC Thin layer chromatography Temp. Temperature Conc. Concentration min Minute NCA No Carrier Added Rf Relative front Rt Retention time CNS Central nervous system Y-indole 4-[2-hydroxy-3- (isopentylamino)propoxy] indole Epidepride N-[(1-ethyl-2- pyrrolidyl)methyl]-2,3- dimethoxy-5-(tributylstannyl) benzamide -
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs GUIDANCE U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) December 2012 Clinical/Medical Guidance Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave. Silver Spring, MD 20993-0002 Phone: 301-796-3400; Fax: 301-847-8714 [email protected] http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) December 2012 Clinical/Medical Contains Nonbinding Recommendations TABLE OF CONTENTS I. INTRODUCTION..............................................................................................................................................1 II. BACKGROUND ................................................................................................................................................1 A. PET DRUGS .....................................................................................................................................................1 B. IND..................................................................................................................................................................2 -
Chapter 3 the Fundamentals of Nuclear Physics Outline Natural
Outline Chapter 3 The Fundamentals of Nuclear • Terms: activity, half life, average life • Nuclear disintegration schemes Physics • Parent-daughter relationships Radiation Dosimetry I • Activation of isotopes Text: H.E Johns and J.R. Cunningham, The physics of radiology, 4th ed. http://www.utoledo.edu/med/depts/radther Natural radioactivity Activity • Activity – number of disintegrations per unit time; • Particles inside a nucleus are in constant motion; directly proportional to the number of atoms can escape if acquire enough energy present • Most lighter atoms with Z<82 (lead) have at least N Average one stable isotope t / ta A N N0e lifetime • All atoms with Z > 82 are radioactive and t disintegrate until a stable isotope is formed ta= 1.44 th • Artificial radioactivity: nucleus can be made A N e0.693t / th A 2t / th unstable upon bombardment with neutrons, high 0 0 Half-life energy protons, etc. • Units: Bq = 1/s, Ci=3.7x 1010 Bq Activity Activity Emitted radiation 1 Example 1 Example 1A • A prostate implant has a half-life of 17 days. • A prostate implant has a half-life of 17 days. If the What percent of the dose is delivered in the first initial dose rate is 10cGy/h, what is the total dose day? N N delivered? t /th t 2 or e Dtotal D0tavg N0 N0 A. 0.5 A. 9 0.693t 0.693t B. 2 t /th 1/17 t 2 2 0.96 B. 29 D D e th dt D h e th C. 4 total 0 0 0.693 0.693t /th 0.6931/17 C. -
A New Gamma Camera for Positron Emission Tomography
INIS-mf—11552 A new gamma camera for Positron Emission Tomography NL89C0813 P. SCHOTANUS A new gamma camera for Positron Emission Tomography A new gamma camera for Positron Emission Tomography PROEFSCHRIFT TER VERKRIJGING VAN DE GRAAD VAN DOCTOR AAN DE TECHNISCHE UNIVERSITEIT DELFT, OP GEZAG VAN DE RECTOR MAGNIFICUS, PROF.DRS. P.A. SCHENCK, IN HET OPENBAAR TE VERDEDIGEN TEN OVERSTAAN VAN EEN COMMISSIE, AANGEWEZEN DOOR HET COLLEGE VAN DECANEN, OP DINSDAG 20 SEPTEMBER 1988TE 16.00 UUR. DOOR PAUL SCHOTANUS '$ DOCTORANDUS IN DE NATUURKUNDE GEBOREN TE EINDHOVEN Dit proefschrift is goedgekeurd door de promotor Prof.dr. A.H. Wapstra s ••I Sommige boeken schijnen geschreven te zijn.niet opdat men er iets uit zou leren, maar opdat men weten zal, dat de schrijver iets geweten heeft. Goethe Contents page 1 Introduction 1 2 Nuclear diagnostics as a tool in medical science; principles and applications 2.1 The position of nuclear diagnostics in medical science 2 2.2 The detection of radiation in nuclear diagnostics: 5 standard techniques 2.3 Positron emission tomography 7 2.4 Positron emitting isotopes 9 2.5 Examples of radiodiagnostic studies with PET 11 2.6 Comparison of PET with other diagnostic techniques 12 3 Detectors for positron emission tomography 3.1 The absorption d 5H keV annihilation radiation in solids 15 3.2 Scintillators for the detection of annihilation radiation 21 3.3 The detection of scintillation light 23 3.4 Alternative ways to detect annihilation radiation 28 3-5 Determination of the point of annihilation: detector geometry, -
Capabilities of Detecting Medical Isotope Facilities Through Radioxenon Sampling
AN ABSTRACT OF THE THESIS OF Matthew R. MacDougall for the degree of Master of Science in Nuclear Engineering presented on June 23, 2015. Title: Capabilities of Detecting Medical Isotope Facilities through Radioxenon Sampling Abstract approved: ______________________________________________________ Andrew C. Klein Medical Isotopes are a necessity in modern medicine for cancer treatments and medical imaging. In order to ensure that the needs and demands are met for the medical procedures, facilities are put in place to produce these isotopes. There are over 25 different isotopes of interest being produced by more than 35 research reactors across the United States. A key component in medical isotope production is the isotope separation process. During this process, several types of radioactive gases are released that would otherwise not leave the nuclear fuel component. One of these radioactive gases is radioxenon. The release of radioxenon into the environment is of concern to the Comprehensive Test Ban Treaty Organization (CTBTO) as one of the key critical sampling techniques utilized to detect a nuclear detonation is the presence of radioxenon. As more facilities release radioxenon, background levels increase, desensitizing the equipment, and making it more difficult to detect. For this purpose, the detection of a medical isotope facility through the use of radioxenon is an interest to the CTBTO as an attempt to reduce the background levels of radioxenon and ensure that the detonation capabilities remain unaffected. This thesis will investigate the capabilities of detecting these medical isotope facilities through the use of radioxenon detection. Additionally, probabilities of detection will be determined in order to accurately identify these facilities. -
Positron Emission Tomography
Positron emission tomography A.M.J. Paans Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands Abstract Positron Emission Tomography (PET) is a method for measuring biochemical and physiological processes in vivo in a quantitative way by using radiopharmaceuticals labelled with positron emitting radionuclides such as 11C, 13N, 15O and 18F and by measuring the annihilation radiation using a coincidence technique. This includes also the measurement of the pharmacokinetics of labelled drugs and the measurement of the effects of drugs on metabolism. Also deviations of normal metabolism can be measured and insight into biological processes responsible for diseases can be obtained. At present the combined PET/CT scanner is the most frequently used scanner for whole-body scanning in the field of oncology. 1 Introduction The idea of in vivo measurement of biological and/or biochemical processes was already envisaged in the 1930s when the first artificially produced radionuclides of the biological important elements carbon, nitrogen and oxygen, which decay under emission of externally detectable radiation, were discovered with help of the then recently developed cyclotron. These radionuclides decay by pure positron emission and the annihilation of positron and electron results in two 511 keV γ-quanta under a relative angle of 180o which are measured in coincidence. This idea of Positron Emission Tomography (PET) could only be realized when the inorganic scintillation detectors for the detection of γ-radiation, the electronics for coincidence measurements, and the computer capacity for data acquisition and image reconstruction became available. For this reason the technical development of PET as a functional in vivo imaging discipline started approximately 30 years ago. -
Neutron Deficient Isotopes of Tellurium and Antimony
UCRL,_.1---,--'_ ~ /t>/,.f oW c-, ( UNIVERSITY OF CALIFORNIA FOR REFERENCE NOT TO BE TAKEN FROM THIS ROOM BERKELEY, CALIFORNIA , • ENG-48 INDEX ITO. ~e:~ -.;;:y ~ This document contains ? pgs, and . plates of figures .-- I: i:BJ·~-;:'--CQPY_.&t.. of' // • Series~ '. e~j" .~ DO NOT RET'40VE LlIS PAGE ----------.._- ~r['N'" '?~,." 1'HIS IS A CLA':'" '-'~~'::::::"".'STF I','P ':i}P~.\'rl.RI=~i1i.3i6TED,.;"-;,- . , ~~~~~-0" .:~.. ",.~. ~~ ---'-clas S":r.iI; ~ i~·nt::6otte'oe;l;"J.m.D.. edhEJre \\ --&~t:' ~l :..'J' ". e}- /; .~ ,s,sWIC-'\l' ti-I'{.t},l J.: li!/er ,.. 'l'bis document contains restrj.cted data within the meaning of ~Rt! ~~ic~rll!¥GY Act of 1946 and/or information affecting the national defense of the :ut~d States within the meaning of the Espionage Act U. S. C. 31 & 32, as amended. Its transmission or the revelation of its contents in an'! manner to an unauthor- ized person is prohibited''';;:na may' r.esult in' severe crimi;,al penalti. Before thisdocument ca.nbei,ivenfoa. person toroad,~his namernust be on the Reading List of those authorized to read material on chis subject, or permissicr must be obtained from the Information Division or the E:l'Zecutive Office. :'i. A SECRET or CONnDENTIAL document is t(') he kept only :I,n a guarded area. 'iVhen stored;-it must be ke'pt-'in a :\.ocked safe or in a lock~d filing case with a twnb ler lock. 4. A SECRIi;T or COnFIDENTIAL document is n('lt tC'l be copied or ctherwise duplicated with0ut ·pormis·s ionOf the originatir..goffice . -
Nuclear Chemistry Why? Nuclear Chemistry Is the Subdiscipline of Chemistry That Is Concerned with Changes in the Nucleus of Elements
Nuclear Chemistry Why? Nuclear chemistry is the subdiscipline of chemistry that is concerned with changes in the nucleus of elements. These changes are the source of radioactivity and nuclear power. Since radioactivity is associated with nuclear power generation, the concomitant disposal of radioactive waste, and some medical procedures, everyone should have a fundamental understanding of radioactivity and nuclear transformations in order to evaluate and discuss these issues intelligently and objectively. Learning Objectives λ Identify how the concentration of radioactive material changes with time. λ Determine nuclear binding energies and the amount of energy released in a nuclear reaction. Success Criteria λ Determine the amount of radioactive material remaining after some period of time. λ Correctly use the relationship between energy and mass to calculate nuclear binding energies and the energy released in nuclear reactions. Resources Chemistry Matter and Change pp. 804-834 Chemistry the Central Science p 831-859 Prerequisites atoms and isotopes New Concepts nuclide, nucleon, radioactivity, α− β− γ−radiation, nuclear reaction equation, daughter nucleus, electron capture, positron, fission, fusion, rate of decay, decay constant, half-life, carbon-14 dating, nuclear binding energy Radioactivity Nucleons two subatomic particles that reside in the nucleus known as protons and neutrons Isotopes Differ in number of neutrons only. They are distinguished by their mass numbers. 233 92U Is Uranium with an atomic mass of 233 and atomic number of 92. The number of neutrons is found by subtraction of the two numbers nuclide applies to a nucleus with a specified number of protons and neutrons. Nuclei that are radioactive are radionuclides and the atoms containing these nuclei are radioisotopes. -
Chapter 16 Nuclear Chemistry
Chapter 16 275 Chapter 16 Nuclear Chemistry Review Skills 16.1 The Nucleus and Radioactivity Nuclear Stability Types of Radioactive Emissions Nuclear Reactions and Nuclear Equations Rates of Radioactive Decay Radioactive Decay Series The Effect of Radiation on the Body 16.2 Uses of Radioactive Substances Medical Uses Carbon-14 Dating Other Uses for Radioactive Nuclides 16.3 Nuclear Energy Nuclear Fission and Electric Power Plants Nuclear Fusion and the Sun Special Topic 16.1: A New Treatment for Brain Cancer Special Topic 16.2: The Origin of the Elements Chapter Glossary Internet: Glossary Quiz Chapter Objectives Review Questions Key Ideas Chapter Problems 276 Study Guide for An Introduction to Chemistry Section Goals and Introductions Section 16.1 The Nucleus and Radioactivity Goals To introduce the new terms nucleon, nucleon number, and nuclide. To show the symbolism used to represent nuclides. To explain why some nuclei are stable and others not. To provide you with a way of predicting nuclear stability. To describe the different types of radioactive decay. To show how nuclear reactions are different from chemical reactions. To show how nuclear equations are different from chemical equations. To show how the rates of radioactive decay can be described with half-life. To explain why short-lived radioactive atoms are in nature. To describe how radiation affects our bodies.. This section provides the basic information that you need to understand radioactive decay. It will also help you understand the many uses of radioactive atoms, including how they are used in medicine and in electricity generation. Section 16.2 Uses of Radioactive Substances Goal: To describe many of the uses of radioactive atoms, including medical uses, archaeological dating, smoke detectors, and food irradiation. -
PET Imaging: an Overview and Instrumentation
CONTINUING EDUCATION PET Imaging: An Overview and Instrumentation Farhad Daghighian, Ronald Sumida, and Michael E. Phelps Division ofNuclear Medicine and Biophysics, Department ofRadiological Sciences; and Laboratory ofNuclear Medicine, Laboratories of Biomedical and Environmental Sciences (DOE)*, UCLA School ofMedicine, Los Angeles, California gen in many chemical compounds. None of the above This is the first article of a four-part series on positron elements have any isotope which emits a gamma ray emission tomography (PET). Upon completing the article, the suitable for imaging with a gamma camera. Hence, one reader should be able to: (1) comprehend the basic principles of the advantages of PET over SPECT is that it deals ofPET; (2) explain various technical aspects; and ( 3) identify with isotopes of those elements that are the building radiopharmaceuticals used in PET imaging. blocks of biomolecules. BRIEF HISTORY Positron emission tomography (PET) is a rapidly growing AND FUTURE OUTLOOK OF PET technique within nuclear medicine. A radiopharmaceutical Positron imaging began with the two-dimensional sodium labeled with a positron emitting isotope is administered intra iodide detector-based scanning devices developed in the late venously or by inhalation to the patient, and the PET scanner 1950s and 1960s by Wrenn et al. ( 4) and Brownell et al. (5). images the distribution of that radiopharmaceutical. It is the Burham and Brownell also developed a dual-headed multi only imaging modality capable of providing quantitative in detector camera that provided a limited form of"focal plane" formation about biochemical and physiologic processes (J- tomography ( 6). Robertson and Niel took a different ap 3). Other techniques like magnetic resonance imaging (MRI) proach and used a "blurring tomography" with a circular and x-ray computerized tomography (CT) generally image array of sodium iodide detectors ( 7). -
Arxiv:1006.4033V2 [Nucl-Ex] 8 Sep 2010
Discovery of Calcium, Indium, Tin, and Platinum Isotopes S. Amos, J. L. Gross, M. Thoennessen∗ National Superconducting Cyclotron Laboratory and Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824, USA Abstract Currently, twenty-four calcium, thirty-eight indium, thirty-eight tin and thirty-nine platinum isotopes have been observed and the discovery of these isotopes is discussed here. For each isotope a brief synopsis of the first refereed publication, including the production and identification method, is presented. arXiv:1006.4033v2 [nucl-ex] 8 Sep 2010 ∗Corresponding author. Email address: [email protected] (M. Thoennessen) Preprint submitted to Atomic Data and Nuclear Data Tables November 1, 2018 Contents 1. Introduction . 4 2. Discovery of 35−58Ca ................................................................................... 5 2.1. 36Ca ............................................................................................ 5 2.2. 37Ca ............................................................................................ 7 2.3. 38Ca ............................................................................................ 7 2.4. 39Ca ............................................................................................ 7 2.5. 40Ca ............................................................................................ 7 2.6. 41Ca ............................................................................................ 8 2.7. 42;43Ca ......................................................................................... -
PRODUCTION STUDY of GADOLINIUM-153 E, H, Acree N. H
PRODUCTION STUDY OF GADOLINIUM-153 F. N. Case E, H, Acree N. H. Cutshall LEGAL NOTICE This report was prepared as an account of Government sponsored work. Neither the United States, nor the Commission, nor any person acting on behalf of the Commission: A. Makes any warranty or representation. expressed or implied, with respect to the accuracy, completeness, or usefulness of the information contained in this report, or that the use of ony information, apparatus, method, or process disclosed in this report may not infringe privately owned rights; or 8. Assumes any liabilities with respect to the use of, or for damages resulting from the use of any informotion, apparatus, method, or process disclosed in this report. As used in the above, "person acting on behalf of the Commission" includes any employee or contractor of the Commission. or employee of such contractor, to the extent that such employee or contractor of the Commission. or employee of such contractor prepares, dissemlnates, or provides access to, any information pursuant to his employment or contract with the Commission, or his employment wtth such contractor. I ORNL-TM-2632 Contract No. W-7405-eng-26 ISOTOPES DEVELOPMENT CENTER PRODUCTION STUDY OF GADOLINIUM-I53 Prepared for NASA, Langley, Hampton, Virginia (Interagency Agreement AEC 40-108-67, MIPR-L-1775) Summary of Results March 1967-December 1968 F. N. Case E. H. Acree N. H. Cutsha I Isotopes Divis on Distribution of this report is provided in the interest of infarmation exchange. Responsibility for the contents resides in the author or orgmization that prepared it. AUGUST 1969 OAK RIDGE NATIONAL LABORATORY Oak Ridge, Tennessee operated by UNION CARBIDE CORPORATION for the U.